Bcl-x Inactivation in Macrophages Accelerates Progression of Advanced Atherosclerotic Lesions in Apoe −/− Mice
Authors:
- Virginie DeswaerteVDVirginie Deswaerte
- Emmanuel L. GautierEGEmmanuel L. Gautier
- Flora Saint-CharlesFSFlora Saint-Charles
- John PiraultJPJohn Pirault
- Laura BouchareychasLBLaura Bouchareychas
- Edmund B. RuckerEREdmund B. Rucker
- Sophie BeliardSBSophie Beliard
- John ChapmanJCJohn Chapman
- Wendy JessupWJWendy Jessup
- Thierry HubyTHThierry Huby
- Philippe LesnikPLPhilippe Lesnik
Open Access
- 1 May 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 32 (5) , 1142-1149
Abstract
Objective—: Bcl-x is the most abundantly expressed member of the Bcl-2 gene family in macrophages, but its role in macrophage apoptosis during atherogenesis is unknown. Methods and Results—: We previously reported dual pro- and antiatherogenic effects of macrophage survival in early versus advanced atherosclerotic lesions, respectively, potentially reflecting growing impairment of efferocytosis during plaque progression. Here, we specifically inactivated Bcl-x in macrophages and evaluated its impact on atherosclerotic lesion formation in Apoe −/− mice at various stages of the disease. Bcl-x deficiency in macrophages increased their susceptibility to apoptosis, resulting in the depletion of tissue macrophages in vivo, including its major pool, Küppfer cells in the liver. We also observed increased cholesterol levels that were, however, not associated with any acceleration of early atherosclerotic plaque progression. This observation suggests that the atheroprotective effect of macrophage apoptosis at that stage of disease was counterbalanced by enhanced cholesterol levels. Bcl-x KO mac /Apoe −/− mice exhibited significantly larger advanced lesions than control mice. These lesions showed vulnerable traits. Such enhanced lesion size may occur as a result not only of apoptotic cell accumulation but also of elevated cholesterol levels. Conclusion—: Modulation of macrophage resistance to apoptosis through targeted deletion of Bcl-x has a major impact on the entire macrophage cell population in the body, including Küpffer cells. Macrophage survival may, therefore, not only influence atherosclerotic plaque development and vulnerability but also cholesterol metabolism.Keywords
This publication has 40 references indexed in Scilit:
- Increased Atherosclerosis in Mice With Vascular ATP-Binding Cassette Transporter G1 Deficiency—Brief ReportArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and FibrosisPLOS Pathogens, 2009
- Brief Report: Increased Apoptosis in Advanced Atherosclerotic Lesions of Apoe −/− Mice Lacking Macrophage Bcl-2Arteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established PlaquesCirculation Research, 2007
- Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stabilityCardiovascular Research, 2007
- Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Lineage-dependent NF-κB activation contributes to the resistance of human macrophages to apoptosisThe Hematology Journal, 2003
- Progression of AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Bcl-xL Expression Correlates with Primary Macrophage Differentiation, Activation of Functional Competence, and Survival and Results from Synergistic Transcriptional Activation by Ets2 and PU.1Journal of Biological Chemistry, 2001